Aruba withdrew the rule that exempted specified low-THC CBD products, including supplements, foods and external-use preparations, from medicinal classification.[1][2] Health minister Dangui Oduber said the December rule did not fully match the intended CBD policy.[1] The health inspectorate’s current guidance treats CBD products with no more than 0.2% THC as medicines requiring permission for commercial import, storage and distribution.[3]
Listed for context. No score change is recorded for Aruba here.
References
- Aruba — Withdrawal of the cannabidiol product exceptions, AB 2020 no. 7Articles I–II; published 16 January, effective 17 January 2020archived
- Aruba — Cannabidiol non-medicinal product exceptions, AB 2019 no. 84Articles 1–3; effective 24 December 2019; later repealedarchived
- Inspectie Volksgezondheid Aruba — Importing CBD productsCurrent official guidance on medicines with no more than 0.2% THC; read 23 October 2026archived
Checked. The date and the event were compared with a source that was read.